Trappc9 deficiency causes parent-of-origin dependent microcephaly and obesity.


Journal

PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074

Informations de publication

Date de publication:
09 2020
Historique:
received: 24 01 2020
accepted: 08 06 2020
entrez: 3 9 2020
pubmed: 3 9 2020
medline: 18 11 2020
Statut: epublish

Résumé

Some imprinted genes exhibit parental origin specific expression bias rather than being transcribed exclusively from one copy. The physiological relevance of this remains poorly understood. In an analysis of brain-specific allele-biased expression, we identified that Trappc9, a cellular trafficking factor, was expressed predominantly (~70%) from the maternally inherited allele. Loss-of-function mutations in human TRAPPC9 cause a rare neurodevelopmental syndrome characterized by microcephaly and obesity. By studying Trappc9 null mice we discovered that homozygous mutant mice showed a reduction in brain size, exploratory activity and social memory, as well as a marked increase in body weight. A role for Trappc9 in energy balance was further supported by increased ad libitum food intake in a child with TRAPPC9 deficiency. Strikingly, heterozygous mice lacking the maternal allele (70% reduced expression) had pathology similar to homozygous mutants, whereas mice lacking the paternal allele (30% reduction) were phenotypically normal. Taken together, we conclude that Trappc9 deficient mice recapitulate key pathological features of TRAPPC9 mutations in humans and identify a role for Trappc9 and its imprinting in controlling brain development and metabolism.

Identifiants

pubmed: 32877400
doi: 10.1371/journal.pgen.1008916
pii: PGENETICS-D-20-00063
pmc: PMC7467316
doi:

Substances chimiques

Intercellular Signaling Peptides and Proteins 0
TRAPPC9 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1008916

Subventions

Organisme : Medical Research Council
ID : MR/J001597/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT095606
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/5
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT098051
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 207462/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12012/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12012/5
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT206194
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R009791/1
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : R35 GM133495
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nat Genet. 2015 May;47(5):544-9
pubmed: 25848752
Hum Mol Genet. 2006 Feb 15;15(4):589-98
pubmed: 16403808
Genetics. 2014 Sep;198(1):59-73
pubmed: 25236449
Am J Hum Genet. 2009 Dec;85(6):903-8
pubmed: 20004764
Curr Biol. 2015 Mar 2;25(5):537-45
pubmed: 25660546
Nucleic Acids Res. 2010 Jan;38(Database issue):D593-9
pubmed: 19854936
Cell Rep. 2015 Jul 21;12(3):449-61
pubmed: 26166566
Eur J Hum Genet. 2013 Feb;21(2):229-32
pubmed: 22549410
Cell. 2013 Jul 18;154(2):452-64
pubmed: 23870131
Nature. 2007 Jan 11;445(7124):168-76
pubmed: 17151600
PLoS Genet. 2012;8(3):e1002600
pubmed: 22479196
Bioinformatics. 2018 Jul 1;34(13):2177-2184
pubmed: 29444201
Nucleic Acids Res. 2001 Jan 1;29(1):275-6
pubmed: 11125110
Nat Genet. 1997 Sep;17(1):12-3
pubmed: 9288087
Brain Res Bull. 2008 Mar 18;75(2-4):340-7
pubmed: 18331896
Am J Hum Genet. 2009 Dec;85(6):909-15
pubmed: 20004765
Nature. 2011 Jan 27;469(7331):534-8
pubmed: 21270893
Physiol Rev. 2009 Jul;89(3):921-56
pubmed: 19584317
Elife. 2015 Jul 03;4:e07860
pubmed: 26140685
Cold Spring Harb Perspect Biol. 2011 Jul 01;3(7):
pubmed: 21576252
Eur J Hum Genet. 2013 Feb;21(2):195-9
pubmed: 22805531
Science. 2010 Aug 6;329(5992):643-8
pubmed: 20616232
Genome Res. 2003 Apr;13(4):558-69
pubmed: 12670997
Eur J Hum Genet. 2011 Nov;19(11):1161-6
pubmed: 21629298
Annu Rev Neurosci. 2016 Jul 8;39:347-84
pubmed: 27145912
Nature. 2011 Jun 15;474(7351):337-42
pubmed: 21677750
Mol Cell Endocrinol. 2015 Feb 15;402:113-9
pubmed: 25578600
Nat Genet. 1997 Jan;15(1):70-3
pubmed: 8988171
Cell Rep. 2015 Aug 11;12(6):979-91
pubmed: 26235621
J Biol Chem. 2005 Aug 12;280(32):29233-41
pubmed: 15951441
Cell. 2016 Jan 28;164(3):353-64
pubmed: 26824653
Hum Mol Genet. 2000 Jul 1;9(11):1587-95
pubmed: 10861285
Genetics. 2015 Jun;200(2):537-49
pubmed: 25858912
Horm Behav. 2011 Jan;59(1):114-22
pubmed: 21056567
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10705-10
pubmed: 23754418
Elife. 2017 Apr 25;6:
pubmed: 28438259
Genes Brain Behav. 2020 Jan;19(1):e12571
pubmed: 30932322
Front Genet. 2019 Feb 11;10:61
pubmed: 30853973
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):9421-9426
pubmed: 28811369
Hum Mol Genet. 2008 May 1;17(9):1336-48
pubmed: 18204050
Curr Opin Genet Dev. 2013 Dec;23(6):642-8
pubmed: 24075575
Eur J Med Genet. 2012 Dec;55(12):727-31
pubmed: 22989526
Annu Rev Genomics Hum Genet. 2014;15:93-126
pubmed: 24898037
Neurology. 2009 Sep 15;73(11):887-97
pubmed: 19752457
J Neurosci. 2013 Oct 23;33(43):17166-73
pubmed: 24155320
PLoS One. 2013 Nov 29;8(11):e80781
pubmed: 24312242
Exp Neurol. 2009 Dec;220(2):341-8
pubmed: 19782683
Am J Hum Genet. 2000 Aug;67(2):476-82
pubmed: 10856193
Am J Hum Genet. 2009 Dec;85(6):897-902
pubmed: 20004763
Nat Rev Mol Cell Biol. 2010 Nov;11(11):759-63
pubmed: 20966969
PLoS One. 2008;3(12):e3839
pubmed: 19052635
Nat Genet. 2015 Apr;47(4):353-60
pubmed: 25730764
Mol Syst Biol. 2011 Jun 07;7:497
pubmed: 21654674
Epigenetics Chromatin. 2014 Mar 25;7(1):5
pubmed: 24667089
Hum Mol Genet. 2009 Aug 15;18(16):3066-74
pubmed: 19487367
Nature. 2011 Sep 14;477(7364):289-94
pubmed: 21921910

Auteurs

Zhengzheng S Liang (ZS)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.

Irene Cimino (I)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.

Binnaz Yalcin (B)

Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université de Strasbourg, France.

Narayanan Raghupathy (N)

The Jackson Laboratory, Bar Harbor, Maine, United States of America.

Valerie E Vancollie (VE)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.

Ximena Ibarra-Soria (X)

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.

Helen V Firth (HV)

Department of Clinical Genetics, Addenbrooke's Hospital, Cambridge, United Kingdom.

Debra Rimmington (D)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.

I Sadaf Farooqi (IS)

University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, United Kingdom.

Christopher J Lelliott (CJ)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.

Steven C Munger (SC)

The Jackson Laboratory, Bar Harbor, Maine, United States of America.

Stephen O'Rahilly (S)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.

Anne C Ferguson-Smith (AC)

Department of Genetics, University of Cambridge, Cambridge, United Kingdom.

Anthony P Coll (AP)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.

Darren W Logan (DW)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH